Prokidney (PROK) EBITDA Margin Growth (1y) (2025 - 2026)
Powered by 
Analysis
Prokidney (PROK) EBITDA Margin Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 377.00 |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | -1.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.43 Mn |
| Mar 31, 2026 | -188,708.00 |
| Dec 31, 2025 | 4.77 Mn |